Comparison of angiogenesis-related factor expression in primary tumor cultures under normal and hypoxic growth conditions

Cancer Cell International

Volumn 8, Issue , 2008, Pages

  Heinzman, Jamie M ^a   Brower, Stacey L ^a   Bush, Jason E ^a  

^a Precision Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FLT3 LIGAND; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPOXIA; LUNG CARCINOMA; OVARY CARCINOMA; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TUMOR GROWTH;

EID: 48249143173     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-8-11     Document Type: Article

References (29)

1. Pilch H Schlenger K Steiner E Brockerhoff P Knapstein P Vaupel P Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts Int J Gynecol Cancer 2001, 11:137-142 10.1046/j.1525-1438.2001.011002137.x 11328412
2. Kuroki M Voest EE Amano S Berrepoot LV Takashima S Tolentino M Kim RY Rohan RM Colby KA Yeo K Adamis AP Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo J Clin Invest 1996:1667-1675 507601 8833917 10.1172/JCI118962
3. Mukherjee A Westwell AD Bradshaw TD Stevens MFG Carmichael J Martin SG Cytotoxic and antiangiogenic activitiy of AW464 (NSC 706704) a novel thioredoxin inhibitor: An in vitro study British Journal of Cancer 2005, 92:350-358 15655539
4. Muller YA Li B Christinger HW Wells JA Cunningham BC DeVos AM Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site Proc Natl Acad Sci 1997, 94:7192-7197 23789 9207067 10.1073/pnas.94.14.7192
5. Mohammed RAA Green A El-Shikh S Paish EC Ellis IO Martin SG Prognostic significance of vascular endothelial growth factors-A, -C, and -D in breast cancer and their relationship with angio- and lymphangiogenesis British Journal of Cancer 2007, 96:1092-1100 10.1038/sj.bjc.6603678 17353919
6. Shi YH Bingle L Gong LH Wang YX Corke KP Fang WG Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells Pathology 2007, 39(4):396-400 10.1080/00313020701444549 17676480
7. Yang JC Haworth L Sherr RM Hwu P Schwartzentruber DJ Topalian SL Steinberg SM Chen HX Rosenberg SA A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cell cancer The New England Journal of Medicine 2003, 349(5):427-434 2275324 12890841 10.1056/NEJMoa021491
8. Wang Y Fei D Vanderlaan M Song A Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro Angiogenesis 2004, 7:335-345 10.1007/s10456-004-8272-2 15886877
9. Hicklin DJ Ellis LM Role of Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis Journal of Clinical Oncology 2005, 23(5):1011-1027 10.1200/JCO.2005.06.081 15585754
10. Shweiki D Itin A Soffer D Keshet E Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 6398:843-5 1992, Oct 29, 1279431
11. Kim KJ Li B Winer J Armanini M Gillett N Phillips HS Ferrara N Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature 1993, 362:841-4 10.1038/362841a0 7683111
12. Brogi E Schatteman G Wu T Kim EA Varticovski L Keyt B Isner JM Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression J Clin Invest 1996, 97(2):69-76 10.1172/ JCI118437
13. Mukhopadhyay D Tsiokas L Zhou XM Foster D Brugge JS Sukhatme VP Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation Nature 357(6532):577-81 1995 Jun 15,
14. Kuhn H Konrad J Holtz S Salsmeh A Gessner C Hammerschmidt S Wirtz H Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines Lung Cancer 2006, 54(2):149-53 10.1016/ j.lungcan.2006.07.016 16934908
15. Cheng M Li Y Wu J Nie Y Li L Liu X Charoude HN Chen H IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells Cytokine 2007 18023202
16. Petreaca ML Yao M Liu Y Defea K Martins-Green M Transactivation of Vascular Endothelial Growth Factor Receptor-2 by Interleukin-8 (IL-8/ CXCL8) is Required for IL-8/CXCL8-induced Endothelial Permeability Mol Biol Cell 2007, 18(12):5014-23 2096609 17928406 10.1091/mbc.E07-01-0004
17. Reinmuth N Rensinghoff S Raedel M Fehrmann N Schwöppe C Kessler T Bisping G Hilberg F Roth GJ Berdel W Thomas M Mesters RM Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells Int J Oncol 2007, 31(3):621-6 17671690
18. Mourskaia AA Northey JJ Siegel PM Targeting aberrant TGF-beta signaling in pre-clinical models of cancer Anticancer Agents Med Chem 2007, 7(5):504-14 17896911
19. De Luca A Carotenuto A Rachiglio A Gallo M Maiello MR Aldinucci D Pinto A Normanno N The role of the EGFR signaling in tumor microenvironment J Cell Physiol 2007
20. Harada S Kimura T Fujiki H Nakagawa H Ueda Y Itoh T Yamagishi H Sonoda Y Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: Possible application for cancer immunotherapy Int J Oncol 2007, 30(6):1461-8 17487367
21. Sato E Fujimoto J Toyoki H Sakaguchi H Alam SM Jahan I Tamaya T Expression of IP-10 related to angiogenesis in uterine cervical cancers Br J Cancer 2007, 96(11):1735-9 10.1038/sj.bjc.6603790 17505511
22. Ignoffo RJ Overview of bevacizumab: A new cancer therapeutic strategy targeting vascular endothelial growth factor Am J Health-Syst Pharm 2004, 61:S21-S26 15552623
23. Maghazachi AA Al-Aoukaty A Schall TJ CC chemokines induce the generation of killer cells from CD56+ cells Eur J Immunol 1996, 26(2):315-9 10.1002/ eji.1830260207 8617297
24. Gallion H Christopherson WA Coleman RL Demars L Herzog T Hosford S Schellhas H Wells A Sevin B-U Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay Int J Gynecol Cancer 2006, 16:194-201 10.1111/j.1525-1438.2006.00301.x 16445633
25. Kenny PA Bissel MJ Tumor reversion: Correction of malignant behaviour by microenvironmental cues International Journal of Cancer 1:168-70 2005, Jan 1,
26. Kim JB Stein R O'Hare MJ Three-dimensional in vitro tissue culture models of breast cancer - a review Breast Cancer Research and Treatment 2004, 85(3):281-91 10.1023/B:BREA.0000025418.88785.2b
27. Heinzman JM Brower SL Bush JE Ex vivo enrichment of malignant carcinoma cells in primary culture Pathology 2007, 39(5):491-4 10.1080/ 00313020701569949 17886099
28. Kornblith P Ochs RL Wells A Gabrin MJ Piwowar J Chattopadhyay A George LD Burholt D Differential in vitro effects of chemotherapeutic agents on primary cultures of human ovarian carcinoma Int J Gynecol Cancer 2004, 14:607-615 10.1111/j.1048-891X.2004.14408.x 15304154
29. Hockel M Vaupel P Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects Journal of the National Cancer Institute 2001, 93(4):266-276 10.1093/jnci/93.4.266 11181773